Back
ESC Premium Access

Peri-procedural treatment with high dose Rosuvastatin reduces soluble TNF receptor 1 in patients treated with primary percutaneous coronary intervention for ST elevation myocardial infarction

Session: Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment
Topic: Inflammation
Speaker: Doctor N. Butt (Stavanger, NO)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Noreen Butt

Stavanger University Hospital, Stavanger (Norway)
0 follower

16 more presentations in this session

Incidence of coronary heart disease in patients with familiar hypercholesterolemia compared to age- and sex- matched controls

Speaker: Doctor K. Svendsen (Oslo, NO)

Access
Abstract
Slides
Like
Thumbnail

Post-procedural cholesterol and inflammatory risk in acute myocardial infarction patients undergoing percutaneous coronary intervention

Speaker: Doctor R. CHEN (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in Poland: results of the TERCET Registry

Speaker: Associate Professor K. Dyrbus (Zabrze, PL)

Access
Abstract
Slides
Like
Thumbnail

Treatment patterns of lipid lowering therapy in patients with coronary artery disease above vs. below 75 years of age

Speaker: Doctor A. Mahabadi (Essen, DE)

Access
Abstract
Like
Thumbnail

Statin treatment in symptomatic patients with non-obstructive coronary artery disease reduces the risk of all-cause mortality

Speaker: Doctor C. Kissel (Zurich, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

Speakers: Doctor N. Butt, Doctor K. Svendsen, Doctor R. CHEN, Associate Professor K. Dyrbus, Doctor A. Mahabadi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources